ERBB2 and intrahepatic cholangiocarcinoma: Three cell lines with borderline HER-2 overexpression (defined as ICC score ≥ 2) and/or HER-3 overexpression were selected for further experimentation, i.e., LS513, LS1034, and SW837 (Additional file 1: Figure S1; Table 1, highlighted in red).